We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Primordial Goo Could Advance Medical Implant Technology

By HospiMedica International staff writers
Posted on 25 Nov 2015
An innovative prebiotic-chemistry inspired polymer coating could help biologically improve medical devices and implants.

Researchers at the Commonwealth Scientific and Industrial Research Organization (CSIRO; Melbourne, Australia) have developed a one-step polymerization-deposition process to manufacture aminomalononitrile (AMN), a hydrogen cyanide (HCN)-derived complex nitrogenous polymer. More...
They found that the polymerization, when carried out in buffered aqueous solutions, can be used to coat a wide range of organic and inorganic substrate materials. The robust, non-cytotoxic coatings also provides for excellent cell attachment, suggesting potential biomedical applications.

According to the researchers, the non-toxic coating chemistry is adhesive and will coat almost any material, thus allowing for the immobilization of other compounds, including metals, both during coating formation or by performing secondary immobilization reactions. Silver compounds, for example, could be added to produce an antibacterial coating for catheters to avoid infections. Other compounds could be added to orthopedic implants to reduce friction, make them more durable and resistant to wear. The study was published on November 13, 2015, in NPG Asia Materials.

“The human body is a complex system, so there is a lot to consider when implanting artificial parts. Reducing the likelihood of infection and ensuring the body doesn't reject implants are ongoing medical challenges; that's why coatings on these implants are needed to help them to do their job,” said senior author Richard Evans, PhD, of the CSIRO manufacturing flagship. “We wanted to use these prehistoric molecules, which are believed to have been the source of all life evolving on Earth, to see if we could apply the chemistry in a practical way.”

Prebiotic chemistry (or chemical evolution) is the study of the chemistry required for producing the key molecules that eventually led to the origin of life. Experimental prebiotic chemistry started with a famous experiment by professor Stanley Miller used methane, hydrogen, ammonia, and an electrical spark to create complex organic compounds. Other HCN polymerization studies showed that prebiotic chemistry could have been a potential source of amino acids, nucleobases, and peptides on earth, and appear to be common throughout the solar system.

Related Links:

Commonwealth Scientific and Industrial Research Organization



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Patient Monitor
IntelliVue MP5SC
New
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Researchers have taken a major step toward cuff-free blood pressure monitoring (Photo courtesy of Gwyneth Moe/Boston University)

Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension

Hypertension affects nearly half of all adults in the U.S. and remains the leading cause of cardiovascular disease. Regular and accurate blood pressure monitoring is essential for managing this condition,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.